650 filings
Page 7 of 33
424B4
2lx7dhl55g
18 Dec 19
Prospectus supplement with pricing info
9:09am
EFFECT
u3321n6uo hg
18 Dec 19
Notice of effectiveness
12:15am
CORRESP
tlfiandrxjs 7aq3r
17 Dec 19
Correspondence with SEC
12:00am
CORRESP
1qlwjv0ew
17 Dec 19
Correspondence with SEC
12:00am
CORRESP
ieoffo8 ovpt
16 Dec 19
Correspondence with SEC
12:00am
CORRESP
kfzxrf17z6bk
16 Dec 19
Correspondence with SEC
12:00am
CORRESP
osa8fgsa
16 Dec 19
Correspondence with SEC
12:00am
CORRESP
4i0zscv8mp p2p4f
12 Dec 19
Correspondence with SEC
12:00am
CORRESP
x7mynmq45uhx4s0u8
10 Dec 19
Correspondence with SEC
12:00am
CORRESP
wwzj17urbt5ns
10 Dec 19
Correspondence with SEC
12:00am
FWP
vblkbfkypc9oo2jqk
2 Dec 19
Free writing prospectus
9:00am
UPLOAD
nwyqe891s6fddtq10y
14 Nov 19
Letter from SEC
12:00am
8-K
g2wmddvy
6 Nov 19
Achieve Reports Financial Results for Third Quarter 2019 and Provides Update on Cytisinicline Development Program
6:51am
8-K
70yo7s
13 Sep 19
Regulation FD Disclosure
12:00am
8-K
onuutt4dbqyw
8 Aug 19
Achieve Reports Financial Results for Second Quarter 2019 and Provides Cytisinicline Clinical Development Update
4:28pm